Triglycerides & CVD: It's about the risk not the number!
Elevated triglycerides remain an independent, under-recognised driver of residual cardiovascular risk, even when LDL-C is well controlled. This session reviews the cardiovascular disease burden, current lipid-lowering therapy options, and NICE/NHS lipid optimisation pathways, before exploring the evidence linking triglyceride reduction to improved cardiovascular outcomes. It concludes with practical strategies for implementing triglyceride-focused risk management in primary care.
UK-VAZK-0308, Sept 2026
